Statin use in low-income and middle-income countries

Lancet Glob Health. 2022 Jul;10(7):e954. doi: 10.1016/S2214-109X(22)00219-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Developing Countries
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Income
  • Poverty

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors